Aude Le Roux

Title: Aude Le Roux: Innovator in Gene Therapy

Introduction

Aude Le Roux is a prominent inventor based in Thiais, France. She has made significant contributions to the field of gene therapy, particularly in the treatment of cancers. With a total of 2 patents, her work focuses on innovative approaches to combat cancer through advanced biotechnological methods.

Latest Patents

Aude Le Roux's latest patents include groundbreaking inventions in the realm of recombinant adenoviruses for gene therapy in cancers. This invention involves recombinant viruses that comprise a heterologous DNA sequence under the control of expression signals specifically active in tumor cells. These viruses are designed for the treatment and prevention of cancers. Another notable patent is related to the in vivo stimulation of angiogenic activity. This method stimulates angiogenesis by introducing two replication-deficient adenovirus vectors to the endothelial cells or nearby cells of an organism. The first vector encodes VEGF-B or a fragment thereof, while the second vector encodes VEGF-A or VEGF-C, or their respective fragments.

Career Highlights

Throughout her career, Aude has worked with various companies, including Gencell, S.A. Her innovative research and development efforts have positioned her as a key figure in the biotechnology sector, particularly in gene therapy.

Collaborations

Aude Le Roux has collaborated with notable professionals in her field, including Berndt Enholm and Didier Branellec. These collaborations have further enhanced her research and contributed to her success as an inventor.

Conclusion

Aude Le Roux is a trailblazer in the field of gene therapy, with her patents paving the way for new treatments in cancer care. Her innovative spirit and dedication to research continue to inspire advancements in biotechnology.